A rare case of scedosporium apiospermum osteomyelitis in an immunocompetent patient.

Caspofungin Dual antifungal therapy Scedosporium Apiospermum Voriconazole

Journal

IDCases
ISSN: 2214-2509
Titre abrégé: IDCases
Pays: Netherlands
ID NLM: 101634540

Informations de publication

Date de publication:
2024
Historique:
received: 16 08 2023
accepted: 29 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: epublish

Résumé

Scedosporium, a widespread filamentous fungus found in diverse environments, has experienced a rise in cases due to escalating malignancies and chronic immunosuppression. Clinical manifestations span mycetoma, airway involvement, and various infections, with osteomyelitis being a notable complication. We present a case of a 77-year-old female initially displaying cutaneous Scedosporium signs, which progressed to osteomyelitis. The patient, with a history of trauma, chronic low dose steroid use, and underlying conditions, presented with a foot injury caused by her dog. Despite initial management, worsening symptoms led to the identification of Scedosporium. A comprehensive approach involving debridement, antimicrobial therapy, and reduction of immunosuppression resulted in clinical improvement. The rarity of zoonotic transmission, diagnostic challenges, and antifungal efficacy are also discussed. The patient's positive trajectory emphasizes early diagnosis, targeted treatment, and vigilance in managing immunosuppression. An adaptable treatment protocol is proposed based on risk factors. Considering the rising opportunistic fungal infections and delayed culture results, initiating empirical antifungals based on clinical judgment and regional prevalence is vital for favorable outcomes.

Identifiants

pubmed: 38327878
doi: 10.1016/j.idcr.2024.e01929
pii: S2214-2509(24)00005-2
pmc: PMC10848027
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e01929

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

Nothing to declare.

Auteurs

Aayushi J Rajani (AJ)

Mayo Clinic Florida, Infectious Disease Department, United States.

Darshankumar Raval (D)

Mayo Clinic Florida, Infectious Disease Department, United States.

Rohit Chitale (R)

Mayo Clinic Florida, Infectious Disease Department, United States.

Ravindra Durvasula (R)

Mayo Clinic Florida, Infectious Disease Department, United States.

Justin Oring (J)

Mayo Clinic Florida, Infectious Disease Department, United States.

Ross Powers (R)

Mayo Clinic Florida, Infectious Disease Department, United States.

Classifications MeSH